SAPPORO CLINICAL LABORATORY INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,076 JPY | -0.37% |
|
-0.74% | +7.49% |
| Sales 2022 | 19.11B 122M 9.72B | Sales 2023 | 20.13B 128M 10.23B | Capitalization | 4.22B 26.91M 2.15B |
|---|---|---|---|---|---|
| Net income 2022 | 1.04B 6.64M 530M | Net income 2023 | 568M 3.62M 289M | EV / Sales 2022 | 0.21 x |
| Net cash position 2022 | 409M 2.61M 208M | Net cash position 2023 | 1.24B 7.89M 629M | EV / Sales 2023 | 0.15 x |
| P/E ratio 2022 |
4.24
x | P/E ratio 2023 |
7.44
x | Employees | 938 |
| Yield 2022 |
1.77% | Yield 2023 |
1.82% | Free-Float | 39.46% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.37% | ||
| 1 week | -0.74% | ||
| Current month | -0.92% | ||
| 1 month | -1.01% | ||
| 3 months | +6.01% | ||
| 6 months | +8.03% | ||
| Current year | +7.49% |
1 week
1 076.00
1 091.00
1 month
1 069.001 111.00
Current year
1 000.001 111.00
1 year
983.001 300.00
3 years
983.001 720.00
5 years
983.002 420.00
10 years
757.002 624.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tadamasa Date
PSD | President | 51 | 31/05/01 |
| Chief Tech/Sci/R&D Officer | - | - | |
Hideo Nagano
BRD | Director/Board Member | 60 | 30/04/85 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chuichi Date
PSD | President | 85 | 01/09/65 |
Tadamasa Date
PSD | President | 51 | 31/05/01 |
Osamu Kuwahara
BRD | Director/Board Member | 64 | 31/03/82 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 1,076 | -0.37% | 1 300 |
| 26/04/24 | 1,080 | 0.00% | 300 |
| 25/04/24 | 1,080 | -0.18% | 100 |
| 24/04/24 | 1,082 | -0.18% | 800 |
| 23/04/24 | 1,084 | +0.93% | 300 |
Delayed Quote Japan Exchange, April 30, 2024 at 05:01 am
More quotes
SAPPORO CLINICAL LABORATORY INC. is a Japan-based company mainly engaged in the dispensing pharmacy business. The Company operates in three business segments. The Clinical Examination segment is engaged in the provision of clinical examination needed in medical examinations in hospitals. The Dispensing Pharmacy segment is engaged in operation of dispensing pharmacies, as well as wholesale of drugs and medicines. The Medical Equipment Sale and Maintenance segment is engaged in the sale and maintenance of high level medical equipment, general medical equipment, as well as physics and chemistry equipment. The others business is engaged in the development, sale and maintenance of software for clinical examination system.
Sector
Drug Retailers
Calendar
12/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +7.49% | 22.85M | |
| -12.48% | 8.57B | |
| +34.94% | 1.32B | |
| +7.12% | 419M | |
| +8.72% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +21.18% | 59.57M |
- Stock Market
- Equities
- 9776 Stock
